Skip to content
← Back to this collection

PUBLICATIONS · 27374467

The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2016 Jul
First author
Cook G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Cook G
      type
      Author
    2. name
      Ashcroft AJ
      type
      Author
    3. name
      Cairns DA
      type
      Author
    4. name
      Williams CD
      type
      Author
    5. name
      Brown JM
      type
      Author
    6. name
      Cavenagh JD
      type
      Author
    7. name
      Snowden JA
      type
      Author
    8. name
      Parrish C
      type
      Author
    9. name
      Yong K
      type
      Author
    10. name
      Cavet J
      type
      Author
    11. name
      Hunter H
      type
      Author
    12. name
      Bird JM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Cook G
      type
      Author
    2. name
      Ashcroft AJ
      type
      Author
    3. name
      Cairns DA
      type
      Author
    4. name
      Williams CD
      type
      Author
    5. name
      Brown JM
      type
      Author
    6. name
      Cavenagh JD
      type
      Author
    7. name
      Snowden JA
      type
      Author
    8. name
      Parrish C
      type
      Author
    9. name
      Yong K
      type
      Author
    10. name
      Cavet J
      type
      Author
    11. name
      Hunter H
      type
      Author
    12. name
      Bird JM
      type
      Author
    bibliography ids
    1. nci-bib-00ee68b490ed9cba0f78e904
    book metadata
    content sha256
    f34a55a5b9b9bdedc33ef85671efab2d84e7829a59c36d8dc4890bb701165bff
    document type
    citation
    dois
    1. 10.1016/S2352-3026(16)30049-7
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27374467
    immutable id
    pubmed:27374467@f34a55a5b9b9bdedc33ef85671efab2d84e7829a59c36d8dc4890bb701165bff
    journal
    abbreviation
    Lancet Haematol
    issn electronic
    2352-3026
    issn print
    Source null
    issue
    7
    name
    The Lancet. Haematology
    nlm unique id
    101643584
    pages
    e340-51
    volume
    3
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27374467
      provenance
      batch id
      d649bcb2d98dbbacd53c
      provider
      NCBI PubMed ESummary
      record sha256
      ca206ba5be7c9fab6aaa0941ca6419fcca594e871c2a84864c8052f6d9a0b04c
      response sha256
      26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
      retrieved at
      2026-09-09T23:47:20.761544+00:00
      publication date
      display
      2016 Jul
      precision
      month
      year
      2016
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27374467/
      title
      The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.

      Preserved source evidence · Not medical advice